Gynecologic and Breast Pathology

Gynecological and breast pathologies, both benign and malignant, have a significant impact on women’s health. An increase in the incidence of certain gynecological and breast cancers is expected, associated with a rise in their environmental risk factors. There is also a growing need to understand and address pathologies that have so far remained invisible, such as uterine myomatosis, endometriosis, menopause, or infertility. This context reinforces the importance of promoting specific lines of research, developed in a highly complex hospital environment and carried out by specialists in the care of these patients. Specialized research allows the integration of care, teaching, and research with a multidisciplinary and translational perspective, fostering continuous improvement in healthcare and in the generation of knowledge.

Main Lines of Research

• Gynecological neoplasms: Endometrial cancer, ovarian cancer, cervical cancer, vulvar cancer, vaginal cancer, breast cancer, and precancerous lesions
• Benign pathologies with a high impact on women’s quality of life: Endometriosis, fibroids, chronic pelvic pain, genital prolapse.
• Gynecological and reproductive endocrinology.

Scientific Challenges

• Early detection and prevention strategies: Developing more accurate and minimally invasive methods for early diagnosis, as well as identifying reliable biomarkers for screening and risk stratification.
• Improving personalized medicine approaches: Advancing precision medicine by identifying molecular and genetic profiles that allow tailored treatments and better prediction of therapeutic response.
• Translational research integration: Bridging the gap between basic research and clinical practice to ensure that scientific discoveries are effectively translated into improved patient outcomes.
• Improving management of chronic benign conditions: Enhancing understanding and treatment of high-impact benign diseases such as endometriosis and fibroids, which remain underdiagnosed and inadequately managed.
• Fertility preservation and reproductive health: Addressing the impact of gynecological diseases and cancer treatments on fertility and developing strategies to preserve reproductive function.
• Quality of life and long-term outcomes: Evaluating and improving long-term survivorship, including physical, psychological, and sexual health outcomes in affected women.

Contact

Silvia Cabrera
scabrera@santpau.cat